- Home
- CTMX vs PHUN Comparison
CTMX vs PHUN Comparison
Compare CTMX & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- PHUN
- Stock Information
- Founded
- CTMX 2008
- PHUN 2009
- Country
- CTMX United States
- PHUN United States
- Employees
- CTMX N/A
- PHUN N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- CTMX Health Care
- PHUN Technology
- Exchange
- CTMX Nasdaq
- PHUN Nasdaq
- Market Cap
- CTMX 444.3M
- PHUN 64.1M
- IPO Year
- CTMX 2015
- PHUN N/A
- Fundamental
- Price
- CTMX $2.41
- PHUN $3.46
- Analyst Decision
- CTMX Strong Buy
- PHUN Buy
- Analyst Count
- CTMX 2
- PHUN 2
- Target Price
- CTMX $5.00
- PHUN $7.75
- AVG Volume (30 Days)
- CTMX 2.6M
- PHUN 360.3K
- Earning Date
- CTMX 08-07-2025
- PHUN 08-07-2025
- Dividend Yield
- CTMX N/A
- PHUN N/A
- EPS Growth
- CTMX 128.27
- PHUN N/A
- EPS
- CTMX 0.49
- PHUN N/A
- Revenue
- CTMX $147,557,000.00
- PHUN $2,956,000.00
- Revenue This Year
- CTMX N/A
- PHUN $3.01
- Revenue Next Year
- CTMX N/A
- PHUN $50.72
- P/E Ratio
- CTMX $5.15
- PHUN N/A
- Revenue Growth
- CTMX 23.81
- PHUN N/A
- 52 Week Low
- CTMX $0.40
- PHUN $2.22
- 52 Week High
- CTMX $3.10
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- CTMX 57.13
- PHUN 60.41
- Support Level
- CTMX $2.15
- PHUN $2.95
- Resistance Level
- CTMX $2.44
- PHUN $3.10
- Average True Range (ATR)
- CTMX 0.22
- PHUN 0.17
- MACD
- CTMX -0.03
- PHUN 0.03
- Stochastic Oscillator
- CTMX 41.67
- PHUN 93.65
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.